Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
5(45%)
Results Posted
33%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
10
91%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

5

trials recruiting

Total Trials

11

all time

Status Distribution
Active(5)
Completed(3)
Terminated(1)
Other(2)

Detailed Status

Recruiting5
Completed3
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
5
Success Rate
75.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (9.1%)
N/A10 (90.9%)

Trials by Status

completed327%
recruiting545%
terminated19%
unknown218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DEVICE
Total Trials
11